US Stock MarketDetailed Quotes

AYTU Aytu BioPharma

Watchlist
  • 1.6650
  • -0.0150-0.89%
Close Jan 31 16:00 ET
  • 1.7500
  • +0.0850+5.11%
Pre 08:50 ET
10.24MMarket Cap-1.09P/E (TTM)

Aytu BioPharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-463.98%-1.19M
72.94%-1.39M
-108.41%-788K
91.26%-254K
94.47%-135K
97.69%-211K
82.21%-5.13M
231.99%9.37M
68.12%-2.91M
72.34%-2.44M
Net income from continuing operations
118.15%1.47M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-1,058.35%-8.12M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
42.04%-6.69M
Operating gains losses
-148.76%-2.88M
191.88%4.4M
-177.37%-1.06M
60.47%-1.02M
141.13%577K
369.60%5.91M
-1,184.99%-4.79M
1,060.84%1.37M
-1,329.44%-2.57M
---1.4M
Depreciation and amortization
-22.57%1.43M
-6.16%8.27M
-8.13%1.94M
-12.45%1.92M
16.32%2.57M
-19.90%1.84M
-13.12%8.82M
-4.68%2.12M
-14.84%2.19M
-17.53%2.21M
Other non cash items
-181.47%-598K
411.91%1.26M
398.23%844K
125.47%161K
-296.73%-482K
174.91%734K
78.17%-403K
61.96%-283K
46.71%-632K
181.61%245K
Change In working capital
36.79%-854K
19.64%-4.66M
-101.71%-42K
-90.30%416K
-49.59%-3.68M
86.60%-1.35M
46.62%-5.8M
139.57%2.46M
222.48%4.29M
-80.90%-2.46M
-Change in receivables
128.38%478K
174.37%5.32M
21.73%6.31M
93.86%-522K
-48.78%1.22M
72.89%-1.68M
-209.49%-7.15M
-11.96%5.18M
-87.29%-8.5M
277.60%2.38M
-Change in inventory
129.79%334K
19.42%-2.91M
-98.39%-1.23M
33.58%-534K
75.95%-19K
46.72%-1.12M
-377.83%-3.61M
-151.49%-622K
-222.00%-804K
79.74%-79K
-Change in prepaid assets
-74.52%119K
80.50%1.53M
-85.08%664K
18.05%1.18M
71.91%-788K
125.93%467K
-62.03%846K
441.24%4.45M
-69.62%1M
-28.97%-2.81M
-Change in payables and accrued expense
52.95%-1.83M
-307.81%-12.45M
-20.43%-5.74M
-98.03%248K
-57.68%-3.08M
-3,761.32%-3.88M
128.56%5.99M
66.29%-4.76M
530.81%12.6M
-173.97%-1.95M
-Change in other working capital
-99.16%41K
305.50%3.85M
97.48%-45K
671.43%40K
-25,300.00%-1.02M
6,861.11%4.87M
-3,844.00%-1.87M
-89,350.00%-1.79M
-800.00%-7K
95.83%-4K
Cash from discontinued investing activities
Operating cash flow
-463.98%-1.19M
72.94%-1.39M
-108.41%-788K
91.26%-254K
94.47%-135K
97.69%-211K
82.21%-5.13M
231.99%9.37M
68.12%-2.91M
72.34%-2.44M
Investing cash flow
Cash flow from continuing investing activities
601.32%381K
-181.20%-329K
78.06%-34K
-4,600.00%-45K
-3,380.00%-174K
-280.95%-76K
96.40%-117K
-278.05%-155K
101.43%1K
99.84%-5K
Net PPE purchase and sale
--381K
----
----
----
----
--0
----
----
----
----
Net other investing changes
----
-181.20%-329K
78.06%-34K
-1,025.00%-45K
---174K
-280.95%-76K
-67.14%-117K
-15,400.00%-155K
90.24%-4K
--0
Cash from discontinued investing activities
Investing cash flow
601.32%381K
-181.20%-329K
78.06%-34K
-4,600.00%-45K
-3,380.00%-174K
-280.95%-76K
96.40%-117K
-278.05%-155K
101.43%1K
99.84%-5K
Financing cash flow
Cash flow from continuing financing activities
133.32%911K
-114.23%-1.26M
119.76%1.07M
-79.48%530K
93.24%-126K
-120.17%-2.73M
479.80%8.87M
-383.80%-5.4M
69.82%2.58M
-128.30%-1.87M
Net issuance payments of debt
481.35%1.41M
19.44%-1.89M
79.26%-1.84M
-81.73%530K
66.46%-212K
-108.71%-370K
55.07%-2.35M
-2,304.73%-8.86M
159.83%2.9M
-123.72%-632K
Net common stock issuance
----
-77.74%3.47M
31.92%3.38M
--0
----
----
33.19%15.58M
354.77%2.56M
-81.73%1.44M
-74.39%1.16M
Net other financing activities
78.85%-500K
34.86%-2.84M
-153.01%-475K
--0
--0
-113.55%-2.36M
11.82%-4.36M
274.66%896K
-16.74%-1.76M
-303.72%-2.39M
Cash from discontinued financing activities
Financing cash flow
133.32%911K
-114.23%-1.26M
119.76%1.07M
-79.48%530K
93.24%-126K
-120.17%-2.73M
479.80%8.87M
-383.80%-5.4M
69.82%2.58M
-128.30%-1.87M
Net cash flow
Beginning cash position
-12.96%20.01M
18.72%22.99M
3.03%19.76M
0.14%19.53M
-16.16%19.96M
18.72%22.99M
-61.20%19.36M
-30.54%19.18M
-44.72%19.5M
-41.29%23.81M
Current changes in cash
103.38%102K
-182.18%-2.98M
-93.54%246K
171.74%231K
89.91%-435K
-167.87%-3.02M
111.87%3.63M
146.12%3.81M
95.80%-322K
18.42%-4.31M
End cash Position
0.72%20.11M
-12.96%20.01M
-12.96%20.01M
3.03%19.76M
0.14%19.53M
-16.16%19.96M
18.72%22.99M
18.72%22.99M
-30.54%19.18M
-44.72%19.5M
Free cash flow
-528.44%-1.33M
72.94%-1.39M
-108.41%-788K
91.26%-254K
94.47%-135K
97.69%-211K
82.21%-5.13M
231.99%9.37M
68.12%-2.91M
72.34%-2.44M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -463.98%-1.19M72.94%-1.39M-108.41%-788K91.26%-254K94.47%-135K97.69%-211K82.21%-5.13M231.99%9.37M68.12%-2.91M72.34%-2.44M
Net income from continuing operations 118.15%1.47M7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-1,058.35%-8.12M84.33%-17.05M84.73%-2.46M86.49%-7.2M42.04%-6.69M
Operating gains losses -148.76%-2.88M191.88%4.4M-177.37%-1.06M60.47%-1.02M141.13%577K369.60%5.91M-1,184.99%-4.79M1,060.84%1.37M-1,329.44%-2.57M---1.4M
Depreciation and amortization -22.57%1.43M-6.16%8.27M-8.13%1.94M-12.45%1.92M16.32%2.57M-19.90%1.84M-13.12%8.82M-4.68%2.12M-14.84%2.19M-17.53%2.21M
Other non cash items -181.47%-598K411.91%1.26M398.23%844K125.47%161K-296.73%-482K174.91%734K78.17%-403K61.96%-283K46.71%-632K181.61%245K
Change In working capital 36.79%-854K19.64%-4.66M-101.71%-42K-90.30%416K-49.59%-3.68M86.60%-1.35M46.62%-5.8M139.57%2.46M222.48%4.29M-80.90%-2.46M
-Change in receivables 128.38%478K174.37%5.32M21.73%6.31M93.86%-522K-48.78%1.22M72.89%-1.68M-209.49%-7.15M-11.96%5.18M-87.29%-8.5M277.60%2.38M
-Change in inventory 129.79%334K19.42%-2.91M-98.39%-1.23M33.58%-534K75.95%-19K46.72%-1.12M-377.83%-3.61M-151.49%-622K-222.00%-804K79.74%-79K
-Change in prepaid assets -74.52%119K80.50%1.53M-85.08%664K18.05%1.18M71.91%-788K125.93%467K-62.03%846K441.24%4.45M-69.62%1M-28.97%-2.81M
-Change in payables and accrued expense 52.95%-1.83M-307.81%-12.45M-20.43%-5.74M-98.03%248K-57.68%-3.08M-3,761.32%-3.88M128.56%5.99M66.29%-4.76M530.81%12.6M-173.97%-1.95M
-Change in other working capital -99.16%41K305.50%3.85M97.48%-45K671.43%40K-25,300.00%-1.02M6,861.11%4.87M-3,844.00%-1.87M-89,350.00%-1.79M-800.00%-7K95.83%-4K
Cash from discontinued investing activities
Operating cash flow -463.98%-1.19M72.94%-1.39M-108.41%-788K91.26%-254K94.47%-135K97.69%-211K82.21%-5.13M231.99%9.37M68.12%-2.91M72.34%-2.44M
Investing cash flow
Cash flow from continuing investing activities 601.32%381K-181.20%-329K78.06%-34K-4,600.00%-45K-3,380.00%-174K-280.95%-76K96.40%-117K-278.05%-155K101.43%1K99.84%-5K
Net PPE purchase and sale --381K------------------0----------------
Net other investing changes -----181.20%-329K78.06%-34K-1,025.00%-45K---174K-280.95%-76K-67.14%-117K-15,400.00%-155K90.24%-4K--0
Cash from discontinued investing activities
Investing cash flow 601.32%381K-181.20%-329K78.06%-34K-4,600.00%-45K-3,380.00%-174K-280.95%-76K96.40%-117K-278.05%-155K101.43%1K99.84%-5K
Financing cash flow
Cash flow from continuing financing activities 133.32%911K-114.23%-1.26M119.76%1.07M-79.48%530K93.24%-126K-120.17%-2.73M479.80%8.87M-383.80%-5.4M69.82%2.58M-128.30%-1.87M
Net issuance payments of debt 481.35%1.41M19.44%-1.89M79.26%-1.84M-81.73%530K66.46%-212K-108.71%-370K55.07%-2.35M-2,304.73%-8.86M159.83%2.9M-123.72%-632K
Net common stock issuance -----77.74%3.47M31.92%3.38M--0--------33.19%15.58M354.77%2.56M-81.73%1.44M-74.39%1.16M
Net other financing activities 78.85%-500K34.86%-2.84M-153.01%-475K--0--0-113.55%-2.36M11.82%-4.36M274.66%896K-16.74%-1.76M-303.72%-2.39M
Cash from discontinued financing activities
Financing cash flow 133.32%911K-114.23%-1.26M119.76%1.07M-79.48%530K93.24%-126K-120.17%-2.73M479.80%8.87M-383.80%-5.4M69.82%2.58M-128.30%-1.87M
Net cash flow
Beginning cash position -12.96%20.01M18.72%22.99M3.03%19.76M0.14%19.53M-16.16%19.96M18.72%22.99M-61.20%19.36M-30.54%19.18M-44.72%19.5M-41.29%23.81M
Current changes in cash 103.38%102K-182.18%-2.98M-93.54%246K171.74%231K89.91%-435K-167.87%-3.02M111.87%3.63M146.12%3.81M95.80%-322K18.42%-4.31M
End cash Position 0.72%20.11M-12.96%20.01M-12.96%20.01M3.03%19.76M0.14%19.53M-16.16%19.96M18.72%22.99M18.72%22.99M-30.54%19.18M-44.72%19.5M
Free cash flow -528.44%-1.33M72.94%-1.39M-108.41%-788K91.26%-254K94.47%-135K97.69%-211K82.21%-5.13M231.99%9.37M68.12%-2.91M72.34%-2.44M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.